Old and new oral anticoagulants: Food, herbal medicines and drug interactions
Top Cited Papers
Open Access
- 1 July 2017
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 31 (4) , 193-203
Abstract
No abstract availableKeywords
This publication has 201 references indexed in Scilit:
- Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa InhibitorAmerican Journal of Cardiovascular Drugs, 2013
- Prophylaxis of venous thromboembolism in elderly patients with multimorbidityInternal and Emergency Medicine, 2013
- Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjectsBritish Journal of Clinical Pharmacology, 2013
- Effect of Herbal Consumption on Time in Therapeutic Range of Warfarin Therapy in Patients With Atrial FibrillationJournal of Cardiovascular Pharmacology, 2011
- Warfarin and vitamin K intake in the era of pharmacogeneticsBritish Journal of Clinical Pharmacology, 2010
- Effect of high‐dose cranberry juice on the pharmacodynamics of warfarin in patientsBritish Journal of Clinical Pharmacology, 2010
- Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal BleedingClinical Pharmacology & Therapeutics, 2008
- Risks and benefits of commonly used herbal medicines in MexicoToxicology and Applied Pharmacology, 2008
- Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interactionEuropean Journal of Clinical Pharmacology, 2007
- Rivaroxaban (BAY 59‐7939) – an oral, direct Factor Xa inhibitor – has no clinically relevant interaction with naproxenBritish Journal of Clinical Pharmacology, 2006